Page last updated: 2024-10-31

neostigmine and Brain Damage, Chronic

neostigmine has been researched along with Brain Damage, Chronic in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laothong, C1
Sitprija, V1

Other Studies

1 other study available for neostigmine and Brain Damage, Chronic

ArticleYear
Decreased parasympathetic activities in Malayan krait (Bungarus candidus) envenoming.
    Toxicon : official journal of the International Society on Toxinology, 2001, Volume: 39, Issue:9

    Topics: Adult; Animals; Autonomic Nervous System Diseases; Brain Damage, Chronic; Bungarus; Child; Female; H

2001